To Örebro University

oru.seÖrebro University Publications
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Editorial: New molecular approaches to improve gynecological cancer management
Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal.
Örebro University, School of Health Sciences. Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID iD: 0000-0001-9992-266x
Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal; Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto)/Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal; 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, Portugal; Department of Pathology, Faculty of Medicine from University of Porto (FMUP), Porto, Portugal.
2023 (English)In: Frontiers in Oncology, E-ISSN 2234-943X, Vol. 13, article id 1235035Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Frontiers Media S.A., 2023. Vol. 13, article id 1235035
Keywords [en]
gynecology oncology, cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, vulvar cancer
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-107059DOI: 10.3389/fonc.2023.1235035ISI: 001023465200001PubMedID: 37416529Scopus ID: 2-s2.0-85164526102OAI: oai:DiVA.org:oru-107059DiVA, id: diva2:1781291
Available from: 2023-07-07 Created: 2023-07-07 Last updated: 2024-01-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Lillsunde-Larsson, Gabriella

Search in DiVA

By author/editor
Lillsunde-Larsson, Gabriella
By organisation
School of Health Sciences
In the same journal
Frontiers in Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 425 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.45.0
|
WCAG
|
Örebro University Library
|
DiVA Portal
|
DiVA Log in
|
Register in DiVA
|
Contact us